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Extranodal marginal zone lymphoma is a low-grade B cell
lymphoma that presents with an indolent clinicopathologic
nature. Although this tumor can occur in various sites,
including the gastrointestinal tract and lungs, it develops and
spreads extremely rarely along the trachea and central airway.
We report a case of extranodal lymphoma of mucosa-asso-
ciated lymphoid tissue with tracheobronchial involvement. An
83-year-old woman presented with a cough and dyspnea.
Bronchoscopic evaluation confirmed diffuse, multiple nodular
lesions in both the trachea and large bronchi, and she was
diagnosed with an extranodal marginal zone lymphoma of the
tracheobronchial tree. After systemic chemotherapy, she
survived for more than 18 months.
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INTRODUCTION
Extranodal marginal zone lymphomas (EMZLs)
were first described by Isaacson and Wright in
1983.
1 They may affect any organ in the body,
including the gastrointestinal tract, lungs, salivary
glands, orbit, thyroid, skin, breast, and urinary
bladder.
2,3 However, EMZLs of mucosa-associated
lymphoid tissue occurring in the trachea is
extremely rare, regardless of whether it is primary
involvement or secondary dissemination.
3,4 With
lung involvement, most pulmonary EMZLs
demonstrate alveolar or nodular patterns on chest
computed tomography (CT).
5-9 Therefore, it is
uncommon for EMZLs of mucosa-associated
lymphoid tissue to initially present as tracheo-
bronchial involvement.
10 Here, we describe a
patient with an extranodal lymphoma of mucosa-
associated lymphoid tissue, mainly occurring
along the trachea and large bronchi, which caused
luminal narrowing of the central airway.
CASE REPORT
An 83-year-old woman presented with a dry
cough and dyspnea for 2 months duration. She
had an 8-kg weight loss over that period, but had
not experienced night sweats or fever. Her
medical, smoking, and family histories were all
noncontributory.
On admission, her physical examination, in-
cluding ear, nose, and throat was unremarkable.
No abnormal laboratory findings were detected.
Chest CT showed diffuse narrowing of the trache-
obronchial tree with endobronchial nodularities,
resulting in the collapse of the right middle lobe
(RML) and small peripheral nodules in both lungs
(Fig. 1). At bronchoscopy, multiple, variable-sized
nodules causing bronchial narrowing were seen
from the proximal trachea to bronchi of both
lungs, including the carina (Fig. 2). Specimens
obtained from the right-second carina revealed
small monophasic lymphoid tumor cells, diffusely
infiltrating the bronchial mucosa, and charac-
teristic lymphoepithelial lesions (Fig. 3). Immuno-
histochemical analysis of these lesions indicated
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82-2-596-2158, E-mail: youngkim@catholic.ac.krFig. 1. CT of the chest shows diffuse narrowing of the tracheobronchial tree with endobronchial nodularities and resultant
collapse of the RML (A), and presence of peripheral nodules in both lungs (B). CT, computed tomography, RML, right
middle lobe.
Fig. 2. Bronchoscopy performed on admis-
sion shows variable-sized nodular lesions
along the tracheobronchial trees (A), and
after chemotherapy, the mucosal abnor-
malities disappeared (B).
Fig. 3. Bronchial mucosal biopsy showing
dense infiltrations of monomorphic lymphoid
tumor cells in the lamina propria (A, × 200,
H & E) and the presence of lymphoepithelial
lesions in the submucosal gland duct (B, ×
200, H & E).
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uniform presence of B-cell markers CD20 and CD
79a, the absence of CD3, CD5, CD23, and
CD45RO, and positive staining for anti-kappa
light chain. Therefore, the lesion was compatible
with an EMZL of mucosa-associated lymphoid
tissue.
We performed CT of the abdomen and neck,
gastrofiberscopy, and a bone marrow biopsy to
establish the stage. The bone marrow biopsy and
gastrofiberscopy indicated no lymphoma involve-
ment. In contrast, CT of the neck and abdomen
showed multiple, variable-sized lymphadeno-
pathies in the cervical area and left pelvic cavity.
Ann Arbor stage IIIE was diagnosed, and 6 cycles
of CVP (cyclophosphamide, vincristine, and
prednisolone) chemotherapy were administered.
After the treatment, follow-up CT of the chest and
abdomen showed improvement of the diffuse
bronchial narrowing and multiple lymphade-
nopathies. At that time, bronchoscopy was per-
formed to evaluate pneumonia. However, we
found no abnormal mucosal lesion in the
tracheobronchial tree or evidence of lymphoma
recurrence in a bronchial biopsy.
DISCUSSION
EMZLs originate from B cell lymphocytes of the
marginal zone in mucosa-associated lymphoid
tissue (MALT). The presence of MALT in the lung
was first described by Bienenstock et al. in 1973,
however, MALT is not a constitutive structure in
the respiratory tract of healthy adults.
11,12 Some
studies have shown that MALT develops in the
areas of antigen exposure and protects the mucosa
by taking up antigens and participating in the
immune mechanism.
13
Primary lymphoma, especially MALT lymphoma,
arising in the trachea is very uncommon.
3,4,14-19 To
the best of our knowledge, only 5 cases of con-
firmed EMZL of the trachea have been
reported.
3,14-17 Based on features of extranodal
lymphoma of MALT, most cases show 1 or a few
nodular lesions localized within the trachea, but
not systemic dissemination. In our case, however,
MALT lymphoma occurred simultaneously in the
trachea and large airways, and systemic involve-
ment was observed at the initial presentation. This
tracheobronchial involvement, either primary or
secondary, is also rare among patients with
lymphoma.
The lung involvement of an EMZL usually
spreads along the bronchovascular bundles and
interlobular septa.
8 Although no specific radio-
graphic findings have been established for MALT
lymphoma of the lung, many studies have
reported that pulmonary nodules and air space
consolidation are major CT patterns.
5-9 In the most
recent published report on CT findings of MALT
lymphoma of the lungs,
9 single or multiple
nodules or consolidations comprised the main
pattern, occurring in 76% of patients, while none
exhibited involvement of the upper respiratory
tract. Therefore, our case is unusual because the
patient initially presented with a characteristic
diffuse endobronchial nodular lesion, as seen on
bronchoscopy and chest CT. This peculiar
spreading pattern readily provided sufficient
samples from the bronchoscopic mucosal biopsy.
The lesion was consistent with a MALT
lymphoma in that it had monophasic small
lymphocytes diffusely infiltrating the bronchial
mucosa, which is a characteristic lymphoepithelial
lesion, and an immunophenotype showing only
B-cell markers and monotypic anti-kappa light
chain positive.
No guidelines for the optimal management of
tracheobronchial MALT lymphomas have been
established.
2,3 Several treatment options exist,
such as surgical resection, radiation, and chemo-
therapy, including anti-CD 20 monoclonal anti-
body, alone or in combination, as well as thera-
peutic abstention. Since our patient had extrapul-
monary involvement and was elderly, she was
treated with the standard CHOP chemotherapy
regimen without adriamycin.
In summary, our patient presented with a
cough and dyspnea and a thorough bronchoscopic
evaluation confirmed an EMZL occurring in both
the trachea and large bronchi. After systemic
chemotherapy, she showed a complete response
and survived for more than 18 months. We should
consider the possibility of EMZL in differentiating
tracheobronchial nodular lesions, because of
specific features of the disease, including an
excellent prognosis.Extranodal Lymphoma with Tracheobronchial Involvement
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